Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction | Zendy

Juan Carlos Ruiz | Zendy; Josep M. Campistol | Zendy; Ana SánchezFructuoso | Zendy; Constantino Fernández Rivera | Zendy; Juan Oliver | Zendy; David RamosBarbón | Zendy; Begoña Campos | Zendy; M. Arias | Zendy; Fritz Diekmann | Zendy

Open Access

Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction

Author(s) -

Juan Carlos Ruiz,

Josep M. Campistol,

Ana SánchezFructuoso,

Constantino Fernández Rivera,

Juan Oliver,

David RamosBarbón,

Begoña Campos,

M. Arias,

Fritz Diekmann

Publication year - 2006

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfl447

Subject(s) - proteinuria , medicine , calcineurin , sirolimus , urology , creatinine , renal function , kidney , gastroenterology , endocrinology , transplantation

Conversion from calcineurin inhibitor to sirolimus, rapamycin has become an option in patients with chronic allograft dysfunction (CAD). However, in many cases an increase of proteinuria has been observed. The aim was to characterize the course of this so far unexplained proteinuria after conversion.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research